These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Measures to meet the side effects of the orally administered antihyperglycemic drugs]. Ishii J; Inoue I Nihon Rinsho; 1997 Nov; 55 Suppl():104-13. PubMed ID: 9434452 [No Abstract] [Full Text] [Related]
3. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes]. Kitaoka H Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035 [No Abstract] [Full Text] [Related]
4. [Alpha-glucosidase inhibitor and insulin sensitizer combination therapy in NIDDM]. Kitaoka H Nihon Rinsho; 1997 Nov; 55 Suppl():192-6. PubMed ID: 9434466 [No Abstract] [Full Text] [Related]
5. [Adverse effects of oral hypoglycemic agents]. Mori Y; Sekihara H Nihon Rinsho; 2002 Sep; 60 Suppl 9():325-31. PubMed ID: 12387013 [No Abstract] [Full Text] [Related]
8. [Pharmacologic profile of oral antidiabetic agents]. Okubo M; Yamane K; Kohno N Nihon Rinsho; 2002 Sep; 60 Suppl 9():310-6. PubMed ID: 12387011 [No Abstract] [Full Text] [Related]
9. [Achieving better control of blood sugar--understanding of oral hypoglycemic agents according to their characteristics in pharmacological action mechanism (discussion)]. Kawamori R; Kadowaki T; Ishida H Nihon Rinsho; 2004 Apr; 62(4):831-9. PubMed ID: 15106356 [No Abstract] [Full Text] [Related]
10. [Current and future aspects of oral antidiabetic agents in type 2 diabetes]. Rybka J Vnitr Lek; 2001 May; 47(5):285-90. PubMed ID: 11395869 [TBL] [Abstract][Full Text] [Related]
12. Pharmacologic management of diabetes mellitus. Mozersky RP J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525 [TBL] [Abstract][Full Text] [Related]
13. Different effects of acarbose and voglibose on serum 1,5-anhydroglucitol concentrations. Sakane N; Yoshida T; Kogure A; Kondo M Diabetes Care; 1998 Mar; 21(3):465-6. PubMed ID: 9540040 [No Abstract] [Full Text] [Related]
14. The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. Haffner SM Endocr Rev; 1998 Oct; 19(5):583-92. PubMed ID: 9793758 [No Abstract] [Full Text] [Related]
16. [alpha-Glucosidase inhibitor, its structure and mechanism of antidiabetic action]. Odaka H Nihon Rinsho; 2002 Sep; 60 Suppl 9():393-8. PubMed ID: 12387024 [No Abstract] [Full Text] [Related]
17. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment. Harrigan RA; Nathan MS; Beattie P Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus. Bressler R; Johnson DG Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological treatment of type 2 diabetes. Hermans MP; Buysschaert M Acta Clin Belg; 2004; 59(2):59-66. PubMed ID: 15224468 [No Abstract] [Full Text] [Related]
20. Oral hypoglycemic agents: the pharmacological basis of their clinical use. Davidoff F R I Med J; 1973 Oct; 56(10):409-14. PubMed ID: 4518221 [No Abstract] [Full Text] [Related] [Next] [New Search]